603 related articles for article (PubMed ID: 28087509)
21. Comparison of Neutrophil Gelatinase-Associated Lipocalin Versus B-Type Natriuretic Peptide and Cystatin C to Predict Early Acute Kidney Injury and Outcome in Patients With Acute Heart Failure.
Palazzuoli A; Ruocco G; Pellegrini M; De Gori C; Del Castillo G; Franci B; Nuti R; Ronco C
Am J Cardiol; 2015 Jul; 116(1):104-11. PubMed ID: 25943992
[TBL] [Abstract][Full Text] [Related]
22. Serum cystatin C is an early predictive biomarker of acute kidney injury after pediatric cardiopulmonary bypass.
Krawczeski CD; Vandevoorde RG; Kathman T; Bennett MR; Woo JG; Wang Y; Griffiths RE; Devarajan P
Clin J Am Soc Nephrol; 2010 Sep; 5(9):1552-7. PubMed ID: 20538834
[TBL] [Abstract][Full Text] [Related]
23. Predictors of outcomes of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with chronic kidney disease.
Kim JH; Yang JH; Choi SH; Song YB; Hahn JY; Choi JH; Lee SH; Gwon HC
Am J Cardiol; 2014 Dec; 114(12):1830-5. PubMed ID: 25438909
[TBL] [Abstract][Full Text] [Related]
24. Serum cystatin is a useful marker for the diagnosis of acute kidney injury in critically ill children: prospective cohort study.
Safdar OY; Shalaby M; Khathlan N; Elattal B; Bin Joubah M; Bukahri E; Saber M; Alahadal A; Aljariry H; Gasim S; Hadadi A; Alqahtani A; Awleyakhan R; Kari JA
BMC Nephrol; 2016 Sep; 17(1):130. PubMed ID: 27624749
[TBL] [Abstract][Full Text] [Related]
25. Association of radial versus femoral access with contrast-induced acute kidney injury in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.
Kolte D; Spence N; Puthawala M; Hyder O; Tuohy CP; Davidson CB; Sheldon MW; Laskey WK; Abbott JD
Cardiovasc Revasc Med; 2016 Dec; 17(8):546-551. PubMed ID: 27566903
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Serum Cystatin C and Creatinine Level Changes for Prognosis of Patients After Peripheral Arterial Angiography.
Yang Y; Zhao X; Tang X; Lu J; Zhou M; Wang W; Wang L; Guo D; Ding F
Angiology; 2015 Sep; 66(8):766-73. PubMed ID: 25344529
[TBL] [Abstract][Full Text] [Related]
27. The discrepancy between serum creatinine and cystatin C can predict renal function after treatment for postrenal acute kidney injury: multicenter study and pooled data analysis.
Matsuki M; Tanaka T; Maehana T; Kyoda Y; Ichihara K; Hashimoto K; Yanase M; Matsukawa M; Adachi H; Takahashi S; Masumori N
Clin Exp Nephrol; 2017 Oct; 21(5):852-857. PubMed ID: 28258496
[TBL] [Abstract][Full Text] [Related]
28. Renal function-based contrast dosing predicts acute kidney injury following transcatheter aortic valve implantation.
Yamamoto M; Hayashida K; Mouillet G; Chevalier B; Meguro K; Watanabe Y; Dubois-Rande JL; Morice MC; Lefèvre T; Teiger E
JACC Cardiovasc Interv; 2013 May; 6(5):479-86. PubMed ID: 23702012
[TBL] [Abstract][Full Text] [Related]
29. Optimum methodology for estimating baseline serum creatinine for the acute kidney injury classification.
Thongprayoon C; Cheungpasitporn W; Kittanamongkolchai W; Srivali N; Ungprasert P; Kashani K
Nephrology (Carlton); 2015 Dec; 20(12):881-6. PubMed ID: 26032233
[TBL] [Abstract][Full Text] [Related]
30. Cystatin C in acute kidney injury diagnosis: early biomarker or alternative to serum creatinine?
Lagos-Arevalo P; Palijan A; Vertullo L; Devarajan P; Bennett MR; Sabbisetti V; Bonventre JV; Ma Q; Gottesman RD; Zappitelli M
Pediatr Nephrol; 2015 Apr; 30(4):665-76. PubMed ID: 25475610
[TBL] [Abstract][Full Text] [Related]
31. Serum cystatin c is not superior to serum creatinine for early diagnosis of contrast-induced nephropathy in patients who underwent angiography.
Xu Q; Wang NN; Duan SB; Liu N; Lei R; Cheng W; Zhou SK
J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27897324
[TBL] [Abstract][Full Text] [Related]
32. Neutrophil Gelatinase-Associated Lipocalin and Contrast-Induced Acute Kidney Injury.
Quintavalle C; Anselmi CV; De Micco F; Roscigno G; Visconti G; Golia B; Focaccio A; Ricciardelli B; Perna E; Papa L; Donnarumma E; Condorelli G; Briguori C
Circ Cardiovasc Interv; 2015 Sep; 8(9):e002673. PubMed ID: 26333343
[TBL] [Abstract][Full Text] [Related]
33. Pre-procedural renal resistive index accurately predicts contrast-induced acute kidney injury in patients with preserved renal function submitted to coronary angiography.
Wybraniec MT; Bożentowicz-Wikarek M; Chudek J; Mizia-Stec K
Int J Cardiovasc Imaging; 2017 May; 33(5):595-604. PubMed ID: 27995343
[TBL] [Abstract][Full Text] [Related]
34. B-type natriuretic peptide and risk of contrast-induced acute kidney injury in acute ST-segment-elevation myocardial infarction: a substudy from the HORIZONS-AMI trial.
Jarai R; Dangas G; Huber K; Xu K; Brodie BR; Witzenbichler B; Metzger DC; Radke PW; Yu J; Claessen BE; Genereux P; Mehran R; Stone GW
Circ Cardiovasc Interv; 2012 Dec; 5(6):813-20. PubMed ID: 23192919
[TBL] [Abstract][Full Text] [Related]
35. Impact of Serum Albumin Levels on Contrast-Induced Acute Kidney Injury in Patients With Acute Coronary Syndromes Treated With Percutaneous Coronary Intervention.
Murat SN; Kurtul A; Yarlioglues M
Angiology; 2015 Sep; 66(8):732-7. PubMed ID: 25260710
[TBL] [Abstract][Full Text] [Related]
36. Urinary renalase concentration in patients with preserved kidney function undergoing coronary angiography.
Wybraniec MT; Bożentowicz-Wikarek M; Chudek J; Mizia-Stec K
Nephrology (Carlton); 2018 Feb; 23(2):133-138. PubMed ID: 27778420
[TBL] [Abstract][Full Text] [Related]
37. Incidence, prognostic impact, and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. insights from the all-comer PRODIGY trial.
Crimi G; Leonardi S; Costa F; Ariotti S; Tebaldi M; Biscaglia S; Valgimigli M
Catheter Cardiovasc Interv; 2015 Jul; 86(1):E19-27. PubMed ID: 25703119
[TBL] [Abstract][Full Text] [Related]
38. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial).
Bolognese L; Falsini G; Schwenke C; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
Am J Cardiol; 2012 Jan; 109(1):67-74. PubMed ID: 21943940
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic and prognostic value of cystatin C in acute heart failure.
Breidthardt T; Sabti Z; Ziller R; Rassouli F; Twerenbold R; Kozhuharov N; Gayat E; Shrestha S; Barata S; Badertscher P; Boeddinghaus J; Nestelberger T; Mueller C
Clin Biochem; 2017 Dec; 50(18):1007-1013. PubMed ID: 28756070
[TBL] [Abstract][Full Text] [Related]
40. Acute kidney injury defined by cystatin C may be superior for predicting the outcomes of liver cirrhosis with acute gastrointestinal bleeding.
Hong C; Zhu Q; Li Y; Tang S; Lin S; Yang Y; Yuan S; Shao L; Wu Y; Liu B; Li B; Meng F; Chen Y; Hong M; Qi X
Ren Fail; 2022 Dec; 44(1):398-406. PubMed ID: 35225149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
